Publications

Latest publication 01/01/2026

Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavi

Introduction: Osteoarthritis (OA) is a degenerative joint condition characterized by chronic pain and the need for pain management. Locally...

Array
(
    [id_prestablog_news] => 2565
    [id_shop] => 1
    [date] => 2026-01-01 00:00:00
    [date_modification] => 2026-01-01 00:00:00
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 4997
    [id_lang] => 1
    [title] => Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavi
    [paragraph] => Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavior
    [content] => 

Authors
Aubrey J. Cooper, Jessica S. Tabman, Raider Rodriguez, Arin Bhattacharjee


Lab
Cognition and Behaviour; European Molecular Biology Laboratory (EMBL); Berkeley; Vienna BioCenter

Journal
bioRxiv

Abstract

Introduction: Osteoarthritis (OA) is a degenerative joint condition characterized by chronic pain and the need for pain management. Locally targeting the endocytotic AP2 complex in nociceptors presents a potential strategy for providing sustained pain relief in individuals with OA. Objective: We investigated whether pain behavior associated with OA can be mitigated by genetically silencing the AP2alpha2 subunit of the AP2 complex in nociceptors and by pharmacologically inhibiting the AP2 complex through the intraarticular administration of a small lipidated decoy peptide. Method: Monoiodoacetate (MIA) was employed to induce knee joint OA in mice and rats. Pain behavior was assessed using dynamic weight-bearing and von Frey filaments. Upon confirmation of established OA pain behavior, in vivo AP2alpha2 genetic knockdown in mice was achieved through sciatic nerve transfection of a targeting AP2alpha2 short hairpin RNA (shRNA). To pharmacologically target endocytosis, a single intraarticular injection of peptide was administered into the arthritic knee of rats. The injection contained either the AP2 inhibitor peptide or a scrambled peptide control. Results: Pain behavior was significantly reduced after both genetic and pharmacological disruption of AP2-driven endocytosis. Animals treated with the Ap2 inhibitor peptide exhibited reduced pain behavior throughout the 28-day assay period. Following the completion of behavioral testing, arthritic knee joints and contralateral healthy knee joints were subsequently collected to assess the impact of the treatment on disease progression. Micro-computed tomography analysis revealed a preservation of bone volume in the arthritic joints that received the AP2 inhibitor peptide treatment, in contrast to the scrambled peptide group. Conclusion: These findings demonstrate that the inhibition of nociceptor endocytosis by a small lipidated peptide presents a promising approach to provide sustained relief from joint pain in individuals with arthritis.

Keywords/Topics
chronic pain; pain management; sustained pain relief; pain behavior; mice; rats; established oa pain behavior; behavioral testing; joint pain; inhibiting nociceptor endocytosis

[meta_description] => [meta_keywords] => https://www.biorxiv.org/content/10.64898/2026.08.21.746311.abstract [meta_title] => [link_rewrite] => Inhibiting-nociceptor-endocytosis-reduces-MIA-induced-osteoarthritic-pain-behavior [actif_langue] => 1 [read] => 25 [count_comments] => 0 [id] => 2565 [categories] => Array ( [70] => Array ( [id_prestablog_categorie] => 70 [title] => Arthritis & Osteoarthritis [link_rewrite] => Arthritis-Osteoarthritis ) [2] => Array ( [id_prestablog_categorie] => 2 [title] => Publications [link_rewrite] => publications ) ) [authors] => [paragraph_crop] => Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavior [link_for_unique] => 1 [products_liaison] => Array ( [1216] => Array ( [name] => Dynamic Weight Bearing 2.0 [description_short] =>

The advanced version of our Dynamic Weight Bearing Test for rodents (rats and mice) allows for faster paw identification, based on a video solution taking advantage of the most advanced algorithms of morphologic analysis, weight distribution and postural changes in dynamic conditions. An efficient and advanced alternative to traditional incapacitance tests (i.e. the paw pressure test or the force plate test) for assessing pain sensitivity in your research on analgesia, hyperalgesia and nociception involving rats and mice, including work on osteoarthritis, bone cancer, analgesic substances, Parkinson disease, allodynia...

Instrument for ratsInstrument for mice

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://bioseb.com/en/pain-spontaneous-pain-postural-deficit/1216-dynamic-weight-bearing-20.html ) [1860] => Array ( [name] => Electronic Von Frey 5 with embedded camera [description_short] =>

As an electronic version of the classical Von Frey Filaments esthesiometer (or aesthesiometer), the latest evolution of Bioseb's Electronic Von Frey instrument for determining the mechanical sensitivity threshold in rodents (rats and mice) is a must-have instrument for your reseach on hyperalgesia and allodynia. By measuring and recording the force at which the animal exhibits a paw withdrawal reflex, pathologies related to sensory response and hyper- or hypo-aesthesia can be studied.

The EVF5 includes an embedded camera inside the stimulator handle and a new, dedicated software revolutionizing the experimental process.

Instrument for ratsInstrument for mice

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://bioseb.com/en/pain-mechanical-allodynia-hyperalgesia/1860-electronic-von-frey-5-with-embedded-camera.html ) ) ) 1
Read more

Filters

Applications

Dates

<< 1 ... 19 20 21 22 23 >>